Case Report – Oral Lichen Planus in a Teenager with Cardiofaciocutaneous Syndrome

Volume : (8), Issue : (10), October - 2020

Abstract : Cardiofaciocutaneous syndrome (CFCS) is an extremely rare genetic disorder that belongs to the group of syndromes known as RAS opathies. The craniofacial and ectodermal manifestations of this syndrome are distinctive and play an important role in the diagnosis of this entity. Nevertheless, there is no scientific evidence to date of the presence of CFCS-related lesions in the oral mucosa. The present study is the first to report the presence of oral lichen planus (OLP) in a patient with CFCS. This finding should be taken into account in the assessment and diagnosis of CFCS in order to establish whether it is an un-related lesion or is associated with the syndrome.

Article: Download PDF Journal DOI : 122/350

Cite This Article:

Article No : 10223

Number of Downloads : 101

References :[1] Tidyman WE, Rauen KA. Noonan, Costello and cardiofacio-cutaneous syndromes: dysregulation of the RasMAPK pathway. Expert Rev Mol Med. 2008; 10:e37. [2] Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.Curr Opin Genet Dev. 2009; 19:230–6. [3] Niihori T, Aoki Y, Narumi Y, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.Nat Genet. 2006; 38:294–6. [4] Rodriguez-Viciana P, Tetsu O, Tidyman WE, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006; 311: 287–90. [5] Roberts AE, Allanson J, Jadico SK, Kavamura MI, Noonan J, Opitz JM, et al. The cardiofaciocutaneous syndrome. J Med Genet. 2006;43:833-42. [6] Narumi Y, Aoki Y, Niihori T, Neri G, Cavé H, Verloes A, et al. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: Overlapping clinical manifestations with Costello syndrome. Am J Med Genet Part A 2007; 143A:799-807. [7] Roberts AE. The clinical phenotype of cardiofaciocutaneous syndrome; in Zenker M (Ed): Noonan Syndrome and related disorders- A Matter of Deregulated Ras Signaling. Monogr Hum Gent Basel, Karger, 2009, vol 17, pp 66-72. [8] Roberts A, Allanson J, Jadico SK, et al. The cardiofaciocutaneous syndrome. J Med Genet. 2006; 43(11):833-42. [9] Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol. 2015; 1(3):140–149. doi:10.1016/j.ijwd.2015.04.001 [10]Boyd AS, Neldner KH. Lichen planus. J. Am. Acad. Dermatol. 1991 Oct; 25(4):593-619 [11] Wagner G., Rose C., Sachse M.M. Clinical variants of lichen planus. J Dtsch Dermatol Ges. 2013; 11(4):309– 319. [12]Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal. 2014; 2014:742826. doi:10.1155/2014/742826. [13] Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N. Engl. J. Med. 2012 Feb 23; 366(8):723-32 [14] Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, Elsaadany BA, Ahmed EM. Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data. Oral Oncol. 2017 May; 68:92-102. Doi: 10.1016/j.oraloncology.2017.03.012. [15]Richards D1. Malignant transformation rates in Oral Lichen Planus. Evid Based Dent. 2018 Dec; 19(4):122. Doi: 10.1038/sj.ebd.6401349.